Cannabis Science Inc (fka CBIS)

[planetaryfuture]

The update on this news released today is very important if one pays close attention to details...

The article focuses on recent research, which demonstrated the ability of Phytocannabinoids to inhibit HIV TAT a vital function of HIV, as well as Cannabis Sciences' recently launched Cannabinoid inhibitory HIV TAT platform called CS-TATI-1.

Cannabis Science is currently the only company looking at the commercial development of a Phytocannabinoid based TAT inhibitor and we hope to understand more about the promise of CS-TATI-1 as it matures through preclinical development," stated Jeannie Wraight, Editor-in-Chief of HIV Haven.

Cannabis Science will also be pursuing other clinical research collaborations including the AIDS Clinical Trials Groups (ACTG), the Canadian AIDS Trial Network (CATN) and the European AIDS Trial Network (EATN).

HIV's ability to mutate and reproduce itself even in the presence of antiretroviral drugs, has led to a growing rate of drug resistance. Increasing drug resistance is severely limiting treatment options for HIV patients around the world, increasing direct and indirect health costs, furthering the spread of drug resistant strains of HIV and is creating a pressing need to develop new HIV drugs.

The U.S. government invests billions of dollars a year in HIV/AIDS research, treatment and care through a variety of
programs. The Ryan White CARE Act, which funds the treatment and care of people living with HIV in the U.S., totals $2.3 billion a year. Among its many other contributions to fighting HIV/AIDS globally, the U.S. provides $22.8 million annually to The U.S. Military HIV Research Program and approximately $1 billion per year to The Global Fund to Fight AIDS, Tuberculosis and Malaria. Pharmaceutical sales to treat HIV equal US $10.6 billion annually. Treatment cost per patient in the U.S. for HIV antivirals alone is approximately US $15,000 a year.

Link to the article...

https://us.etrade.com/e/t/invest/Story?ID=STORYID%3Detrade_2012_06_13_eng-etrade_cbs2_market_watch_eng-etrade_cbs2_market_watch_934E0CFB-6B7D-407F-A968-7A58EC1413E7&provider=BusinessWire

Best Wishes